Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Ismael García-Moguel, Ana Rosado, Aída Gómez-Cardeñosa, Mar Gandolfo-Cano, Teresa Robledo Echarren, Maria del Mar Moro Moro, Mª del Mar Reaño Martos, Rafael Pineda-Pineda, Marcela Valverde-Monge, Cristina Martin-Arriscado Arroba & Javier Domínguez-Ortega. (2022) Reliability, Satisfaction and Effectiveness of Benralizumab Home Self-Administration in Patients with Severe Eosinophilic Asthma in Real-World Practice: The Auto-Benra Study. Journal of Asthma and Allergy 15, pages 623-632.
Read now
Read now
Francesco Menzella, Matteo Fontana, Patrizia Ruggiero, Francesco Livrieri & Nicola Facciolongo. (2022) Home-based treatment of biologics for asthma: who, what, where, when and why. Expert Review of Respiratory Medicine 16:4, pages 419-428.
Read now
Read now
Sady Alpizar, Ayman Megally, Claudia Chen, Abhi Raj, John Downie & Gene Colice. (2021) Functionality and Performance of an Accessorized Pre-Filled Syringe and an Autoinjector for At-Home Administration of Tezepelumab in Patients with Severe, Uncontrolled Asthma. Journal of Asthma and Allergy 14, pages 381-392.
Read now
Read now
Francesco Menzella, Emanuele Ferrari, Silvia Mariel Ferrucci, Enrico Lombardi, Silvio Alfano, Ornella Bonavita, Paolo Morini, Andrea Rizzi & Andrea Matucci. (2021) Self-administration of omalizumab: why not? A literature review and expert opinion. Expert Opinion on Biological Therapy 21:4, pages 499-507.
Read now
Read now
Ubaldo J. Martin, Rainard Fuhr, Pablo Forte, Peter Barker, Milton J. Axley, Magnus Aurivillius, Li Yan & Lorin Roskos. (2021) Comparison of autoinjector with accessorized prefilled syringe for benralizumab pharmacokinetic exposure: AMES trial results. Journal of Asthma 58:1, pages 93-101.
Read now
Read now
Alessandro Vatrella, Angelantonio Maglio, Simona Pellegrino, Corrado Pelaia, Cristiana Stellato, Girolamo Pelaia & Carolina Vitale. (2020) Phenotyping severe asthma: a rationale for biologic therapy. Expert Review of Precision Medicine and Drug Development 5:4, pages 265-274.
Read now
Read now
Gary T Ferguson, Jeremy Cole, Magnus Aurivillius, Paul Roussel, Peter Barker & Ubaldo J Martin. (2019) Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results. Journal of Asthma and Allergy 12, pages 363-373.
Read now
Read now
Francesco Menzella, Manuela Latorre, Patrizia Ruggiero, Diego Bagnasco & Enrico Heffler. (2019) Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?. Expert Opinion on Biological Therapy 19:7, pages 601-606.
Read now
Read now
Diego Jose Maselli, Linda Rogers & Jay I Peters. (2018) Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use. Therapeutics and Clinical Risk Management 14, pages 2059-2068.
Read now
Read now
Khalid Al Efraij & J. Mark FitzGerald. (2018) Benralizumab for the add-on maintenance treatment of patients with severe asthma aged 12 years and older with an eosinophilic phenotype. Expert Review of Clinical Pharmacology 11:7, pages 669-676.
Read now
Read now
Articles from other publishers (8)
Ming-Li Chen, Tanawin Nopsopon & Ayobami Akenroye. (2023) Incidence of Anti-Drug Antibodies to Monoclonal Antibodies in Asthma: A Systematic Review and Meta-Analysis. The Journal of Allergy and Clinical Immunology: In Practice 11:5, pages 1475-1484.e20.
Crossref
Crossref
Kai Huang, Nannan Chu, Ying Ding, Linglin Que, Zhenzhong Qian, Yunfei Shi, Wei Qin & Qing He. (2022) Comparative Pharmacokinetics, Safety, and Immunogenicity Study of the Prefilled Syringe and Lyophilized Formulation of a Recombinant Human Tumor Necrosis Factor‐α Receptor II:lgG Fc Fusion Protein in Healthy Chinese Male Subjects. Clinical Pharmacology in Drug Development 11:9, pages 1116-1123.
Crossref
Crossref
S.A. Bendien, M.M. van Leeuwen, H.S. Lau, A. Ten Brinke, L.E. Visser, E.M. de Koning & G.J. Braunstahl. (2022) Home-based intravenous treatment with reslizumab for severe asthma in the Netherlands – An evaluation. Respiratory Medicine 194, pages 106776.
Crossref
Crossref
Madhur D. Shastri, Wai Chin Chong, Kamal Dua, Gregory M. Peterson, Rahul P. Patel, Malik Q. Mahmood, Murtaza Tambuwala, Dinesh K. Chellappan, Nicole G. Hansbro, Shakti D. Shukla & Philip M. Hansbro. (2020) Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators. Inflammopharmacology 29:1, pages 15-33.
Crossref
Crossref
Cecelia C. Damask, Matthew W. Ryan, Thomas B. Casale, Mario Castro, Christine B. Franzese, Stella E. Lee, Joshua M. Levy, Sandra Y. Lin, Peter A. Lio, Anju T. Peters, Michael P. Platt & Andrew A. White. (2020) Targeted Molecular Therapies in Allergy and Rhinology. Otolaryngology–Head and Neck Surgery 164:S1.
Crossref
Crossref
Genny Chaia, Ubaldo Martín, Arturo Cortés-Telles, Fernando Morett, José Julio Gutiérrez-Mujica, Adriana Zepeda-Gómez, Alberto Hegewisch & Rogelio Ramses Hernández. (2020) Benralizumab: eficacia y seguridad en pacientes con asma grave eosinofílica.. Revista Alergia México 67.
Crossref
Crossref
Carlo Lombardi, Diego Bagnasco & Giovanni Passalacqua. (2020) Biological agents for severe asthma: the evolution of the at-home self-injection approach. Current Opinion in Allergy & Clinical Immunology 20:4, pages 421-427.
Crossref
Crossref
Carlo Lombardi, Giovanni Passalacqua & Diego Bagnasco. (2019) Severe asthma, biologicals, and auto‐injection: Yes, no, may be!. Allergy 75:2, pages 444-445.
Crossref
Crossref